| Title |
Credit (Amnt/Type) |
Est.Time |
Expires |
|
Case Study 1: Prevention of VTE in an Elderly Woman With Pneumonia
|
0.50 / AMA PRA Category 1 Credit(s)™
|
30 Minutes |
August 31, 2010 |
Emerging Targeted Therapies for Hematologic Malignancies:
Leaving a Genetic and Epigenetic Imprint for Better Outcomes
|
1.50 / AMA PRA Category 1 Credit(s)™
|
90 Minutes |
November 30, 2010 |
|
New Drugs/Indications (Issue #1)
|
1.00 / AMA PRA Category 1 Credit(s)™
1.00 / CE for Pharmacists
|
1 Hour |
April 30, 2010 |
Nursing Challenges in the Management of Acute Coronary Syndrome:
A Clinical Curriculum on Antiplatelet Therapies
|
2.00 / CE for Nurses
|
2 Hours |
January 13, 2011 |
|
Preventing VTE in the Community: Best Practices for the Establishment & Management of an Outpatient VTE Prevention Program
|
2.00 / AMA PRA Category 1 Credit(s)™
1.00 / CE for Nurses
2.00 / CE for Pharmacists
|
2 Hours |
July 31, 2011 |
|
Recent Advances in The Treatment Of Hematologic Malignancies
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
January 15, 2010 |
Recent Advances in the Treatment of Hematologic Malignancies:
Highlights from the 50th Annual Meeting of ASH
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
April 30, 2010 |
|
Survival after High-Dose Therapy and Autologous Transplantation in Chemoresistant HL
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
February 15, 2010 |
|
The Primary Care Clinician's Pivotal Role in the Prevention, Diagnosis, and Treatment of Venous Thromboembolism
|
2.00 / AMA PRA Category 1 Credit(s)™
|
2 Hours |
July 31, 2010 |
|
Thromboembolism in Cancer Patients: A Cogent Approach to Risk Assessment, Prevention, and Treatment
|
1.75 / AMA PRA Category 1 Credit(s)™
|
105 Minutes |
May 31, 2010 |